Generic-drug makers to lobby to get products to market faster

10/14/2009 | Roll Call (subscription required)

Now that the Senate Finance Committee has passed its version of the health care reform bill, the generic-drug industry will begin lobbying lawmakers on provisions that could determine how quickly generic versions of biologic drugs can be marketed. Brand-name biologic manufacturers want to hold off generics for 12 years, but generics makers argue the time frame should be reduced to no more than seven years to reduce health care spending. "The current bill is not going to provide needed access to affordable lifesaving medicines," the president of the Generic Pharmaceutical Association said.

View Full Article in:

Roll Call (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC